Inclusion Criteria | |
● Ages 18 years and older | |
● Meets DSM-5 criteria for MDD (as documented by the TMS physician) | |
● Meet study criteria for pharmacoresistance in accordance with the Clinical TMS Program (i.e. failed at least one antidepressant in the current episode) | |
● Ability to obtain a motor threshold (MT) prior to the start of treatment | |
● Stable medical conditions and ability to maintain stability on current medication regimen for the duration of treatment | |
● Ability to participate in a daily treatment regimen | |
● Able to read, verbalize understanding, and voluntarily sign the Informed Consent Form prior to participating in any study-specific procedures or assessments | |
Exclusion Criteria | |
● History of seizure disorder | |
● Structural or neurologic abnormalities present or in close proximity to the treatment site | |
● History of brain surgery | |
● Pacemaker or medical infusion device (unless MRI compatible) | |
● History of traumatic brain injury within 60 days of the start of treatment | |
● Severe or uncontrolled alcohol or substance use disorders | |
● Active withdrawal from alcohol or substances | |
● Implanted device in the head | |
● Metal in the head | |
● Severe impediment to vision, hearing and/or hand movement, likely to interfere with ability to complete the assessments, or unable and/or unlikely to follow the study protocols | |
● Lifetime history of bipolar I disorder | |
● Inability to speak, read or understand English | |
● Plans to move out of the area during the study period | |
● Clinician and/or Investigator discretion for clinical safety or protocol adherence |